Skip to content

PP&E (Net) at other companies

AbbVie logo
AbbVieABBV
$5.69B+8.6%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$102.57M-1.8%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$13.59M-27.5%
Opko Health logo
Opko HealthOPK
$72.59M+2.0%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$81.51M-16.7%
Regenxbio logo
RegenxbioRGNX
$101.87M-11.0%

Other financials

Income statement

See full
Revenue$2.2M-50.6%
Operating income-$14.4M-44.7%
Net income-$65.5M-700%
EPS (diluted)-$0.75-213%

Balance sheet

See full
Cash & equivalents$60.0M+43.5%
Total debt$1.2M
Total equity-$45.8M-1,004%
Total assets$66.8M+38.7%

Cash flow

See full
Operating cash flow-$12.7M-41.5%

Valuation

See full
Market cap$307.14M+442%
Enterprise value$248.38M
P/S25.6×+21.5×

Profitability

See full
Operating margin-359.1%-68.9pp
Net margin-892.4%-12,322pp

Returns & leverage

See full
Return on equity-449.4%-2,573pp
Debt / equity0.1×
Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Opus Genetics's PP&E (net)?
Opus Genetics (IRD) reported PP&E (net) of $186K in Q1 2026.
How has Opus Genetics's PP&E (net) changed year-over-year?
Opus Genetics's PP&E (net) decreased by 22.2% year-over-year, from $239K to $186K.
What is the long-term trend for Opus Genetics's PP&E (net)?
Over 5 years (2020 to 2025), Opus Genetics's PP&E (net) has grown at a 70.0% compound annual growth rate (CAGR), from $14K to $199K.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.